Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Steris secures $1.6 billion revolving credit facility

By Public Technologies
  • Steris entered a $1.6 billion revolving credit agreement on November 4, 2026, replacing its October 7, 2024 agreement.
  • The revolver matures November 4, 2031, with commitments eligible to increase by up to $800 million, subject to conditions.
  • FinCo separately secured a delayed draw term loan facility of up to $500 million, with J.P. Morgan SE as administrative agent.
  • The term loan requires completion of the Xodus Medical acquisition before funding; maturity falls five years after the acquisition closes.
  • Both facilities carry floating interest rates with margins determined by the company's debt rating.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Steris plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-447617), on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.